In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits | With a $2.2 billion ...

All the companies have insisted they will defend themselves vigorously in the lawsuits ... or reliable evidence that ranitidine increases the risk of any cancer.” “Yesterday’s ruling ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit in the U.S. District Court for the Eastern District of Pennsylvania alleging ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

The UK-based pharmaceutical company has been the target of numerous lawsuits ... causes cancer, and that the company failed to warn users that its main ingredient—ranitidine—may be a human ...

A class action lawsuit has already been filed ... is no evidence of a causal association between ranitidine therapy and the development of cancer in patients," findings that were "consistent ...

the FDA requested that manufacturers cease selling Zantac and any generic alternatives. Tens of thousands of cancer-stricken patients filed personal injury and product liability lawsuits against ...